Cart
sales@molnova.com
MAO-B-IN-5
CAS No. 849909-77-9
MAO-B-IN-5( —— )
Catalog No. M37657 CAS No. 849909-77-9
MAO-B-IN-5 is a potent, selective, and orally active MAO-B inhibitor with an IC50 of 0.204 μM, showing potential for research in Parkinson's disease (PD) .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 236 | Get Quote |
|
| 5MG | 366 | Get Quote |
|
| 10MG | 521 | Get Quote |
|
| 25MG | 756 | Get Quote |
|
| 50MG | 1021 | Get Quote |
|
| 100MG | 1350 | Get Quote |
|
| 200MG | 1764 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMAO-B-IN-5
-
NoteResearch use only, not for human use.
-
Brief DescriptionMAO-B-IN-5 is a potent, selective, and orally active MAO-B inhibitor with an IC50 of 0.204 μM, showing potential for research in Parkinson's disease (PD) .
-
DescriptionMAO-B-IN-5 is a potent, selective and orally active MAO-B inhibitor with an IC50 of 0.204 μM. MAO-B-IN-5 has the potential for the research of Parkinson's disease (PD).
-
In VitroMAO-B-IN-5 (compound D0) (Sf9 cells) shows inhibitory activities towards MAO with the IC50s of 34.190 μM and 0.204 μM for MAO-A and MAO-B, respectively.
-
In VivoMAO-B-IN-5 (1 mg/kg, i.v.; 5 mg/kg, p.o.) shows oral bioavailability in rats (F=13.6%).Pharmacokinetic Parameters of MAO-B-IN-5 in SD rats.SD rats; 1 mg/kg, i.v.; 5 mg/kg, p.o..Animal Model:SD rats Dosage:1, 5 mg/kg Administration:1 mg/kg, i.v.; 5 mg/kg, p.o.Result:Showed oral bioavailability in rats (F=16.3%).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number849909-77-9
-
Formula Weight328.38
-
Molecular FormulaC19H21FN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N1[C@H](C(N)=O)CCC1)C2=CC=C(OCC3=CC(F)=CC=C3)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang Z,et al. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study. Eur J Med Chem. 2022; 228:114025.?
molnova catalog
related products
-
Hederasaponin B
Hederasaponin B has antiviral activity, via inhibiting the viral VP2 protein expression and blocking viral capsid protein synthesis.
-
IFN alpha-IFNAR-IN-1...
IFN alpha-IFNAR-IN-1 hydrochloride is an inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 hydrochloride inhibits MVA-induced IFN-α responses by BM-pDCs with IC50 of 2-8 μM.
-
G-1749
G-1749 does not alter the monomer-dimer equilibrium of IRE, stimulates the RNase activity of unphosphorylated IRE1 and inhibits IRE1-3P, and significantly increases the RNase activity of IRE1-KR-0P.
